Impaired glucose tolerance

Table 1.a | Top 10: Prevalence of impaired glucose tolerance* (20-79 age group), 2007

  Country/territory

2007
Prevalence

(%)

     
1 Nauru

20.4

2 United Arab Emirates

18.7

3 Bahrain

18.7

4 Kuwait

18.7

5 Singapore

18.7

6 Kiribati

17.3

7 Mauritius

16.3

8 Poland

15.2

9 Tonga

13.0

10 Denmark

12.4

Table 1.b | Top 10: Prevalence of impaired glucose tolerance* (20-79 age group), 2025 
  Country/territory

2025
Prevalence

(%)

     
1 Nauru

21.2

2 Bahrain

19.9

3 United Arab Emirates

19.9

4 Kuwait

19.9

5 Singapore

19.7

6 Kiribati

18.1

7 Mauritius

17.0

8 Poland

16.3

9 Ghana

15.0

10 Tonga

13.8

* comparative prevalence
Includes only countries where surveys with glucose testing were undertaken for that country

Table 2.a | Top 10: Number of people with impaired glucose tolerance (20-79 age group), 2007 

  Country/territory

2007 
Persons

(millions)

     
1 China

64.3

2 India

35.9

3 Russian Federation

17.8

4 Indonesia

14.1

5 Japan

12.9

6 United Stqtes of America

12.4

7 Brazil

8.4

8 Bangladesh

6.8

9 Pakistan

6.4

10 Ukraine

6.0

Table 2.b | Top 10: Number of people with impaired glucose tolerance (20-79 age group), 2025
  Country/territory

2025
Persons

(Millions)

     
1 China

79.1

2 India

56.2

3 Indonesia

20.6

4 Russian Federation

17.8

5 United States of America

16.5

6 Japan

12.7

7 Brazil

11.5

8 Pakistan

11.0

9 Bangladesh

10.6

10 Mexico

7.7

Table 3.a | Regional estimates for impaired glucose tolerance (IGT) (20-79 age group), 2007

 2007

 

   

 Region

Population
(20-79)

millions
No. of
people with
IGT


millions
IGT
prevalence*

%

 

   
AFR

336 

24.2

8.2

EMME

 318

22.4

8.1

EUR

 634

65.3

9.1

NA

 306

19.6

5.8

SACA

 272

19.8

7.5

SEA

 770

45.2

6.0

WP

 1,469

111.9

7.5

 

 

 

TOTAL

 4,107

308.3

7.5

Table 3.b | Regional estimates for impaired glucose tolerance (IGT) (20-79 age group), 2025
 2025

 

   

 Region

Population
(20-79)

millions
No. of
people with
IGT


millions
IGT
prevalence*

%

 

   
AFR

537

40.3

9.2

EMME

 492

38.6

8.8

EUR

 653

71.2

9.6

NA

 376

27.5

6.7

SACA

 364

27.6

7.9

SEA

 1,083

70.5

6.7

WP

1,732

142.7

7.8

 

 

 

TOTAL

 5,237

418.4

8.1

Table 3.c | Regional estimates for impaired glucose tolerance (IGT) (20-79 age group), 2007 and 2025
 2007/2025

 

 Region

Increase in the
no. of people with IGT

%

 

AFR

66.9

EMME

72.4

EUR

9.0

NA

40.3

SACA

39.4

SEA

 56.1

WP

 27.5

 

TOTAL

 35.7